Acarbose | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Acarbose
Canada

Evonik

Contact Supplier

Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Acarbose

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 9 USDMF, 6 CEP/COS, 3 JDMF, 2 KDMF, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

13 API Suppliers
9 USDMF
6 CEP/COS
3 JDMF
2 KDMF
5 NDC API
6 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

112 FDF Dossiers, 27 FDA Orange Book, 41 Europe, 4 Canada, 8 Australia, 2 South Africa, 30 Listed Dossiers

112 FDF Dossiers
27 FDA Orange Book
41 Europe
4 Canada
8 Australia
2 South Africa
30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 10 Gangwal Healthcare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 4 Kerry, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Vasa Pharmachem

4 SPI Pharma
1 DKSH
1 Jai Radhe Sales
10 Gangwal Healthcare
6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
3 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
3 Ingredion Pharma Solutions
4 Kerry
7 Microlex e.U
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
14 Roquette
1 Seppic
4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

34 Fillers, Diluents & Binders, 20 Direct Compression, 18 Disintegrants & Superdisintegrants, 12 Thickeners and Stabilizers, 11 Lubricants & Glidants, 11 Co-Processed Excipients, 8 Granulation, 5 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 5 Taste Masking, 3 Emulsifying Agents, 3 Coating Systems & Additives, 2 Rheology Modifiers, 1 Film Formers & Plasticizers, 1 API Stability Enhancers

34 Fillers, Diluents & Binders
20 Direct Compression
18 Disintegrants & Superdisintegrants
12 Thickeners and Stabilizers
11 Lubricants & Glidants
11 Co-Processed Excipients
8 Granulation
5 Controlled & Modified Release
5 Chewable & Orodispersible Aids
5 Taste Masking
3 Emulsifying Agents
3 Coating Systems & Additives
2 Rheology Modifiers
1 Film Formers & Plasticizers
1 API Stability Enhancers

DIGITAL CONTENT

4 NEWS #PharmaBuzz

4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 45 Finished Drug Prices, 6 Annual Reports

1 US Medicaid Prescriptions
45 Finished Drug Prices
6 Annual Reports

MARKET PLACE

12 APIs, 1 FDF Dossiers

12 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 2 Others

3 EDQM
2 USP
2 Others

$ API Ref.Price (USD/KG) : 469 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 2MARCAN PHARMACEUTICALS INC

02 2MINT PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

4 All

01 4ACARBOSE

filter Dosage Form Reset all filters

4 All

01 4TABLET

filter Brand Name Reset all filters

4 All

01 2MAR-ACARBOSE

02 2MINT-ACARBOSE

List of Suppliers

Product Main Page

01

MARCAN PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

MARCAN PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MAR-ACARBOSE

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2494078

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

MARCAN PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

MARCAN PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MAR-ACARBOSE

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 2494086

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MINT PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

MINT PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MINT-ACARBOSE

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2493780

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MINT PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

MINT PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MINT-ACARBOSE

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 2493799

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?